US Stock MarketDetailed Quotes

MGRX Mangoceuticals

Watchlist

2.620
-0.030-1.13%

Close Nov 25 16:00 ET

2.600
-0.020-0.76%

Post 18:36 ET

6.51MMarket Cap-599P/E (TTM)

Mangoceuticals Stock Forum

Andy-Lai

Nov 11 10:09

JTAl Jet.Al

$Mangoceuticals (MGRX.US)$

JiuShini

Nov 1 09:54

$Mangoceuticals (MGRX.US)$ as expected, regains fully complaince which means they dont have to pump it already, free fall

Trytosaveabit

Oct 31 07:01

Update

$Mangoceuticals (MGRX.US)$ Mangoceuticals, Inc. Regains Full Compliance With Nasdaq Minimum Bid Price Requirement

Jaguar8

Oct 22 07:06

NEWS

$Mangoceuticals (MGRX.US)$
MangoRx Announces Formation of Strategy and Alternatives Committee
MangoRx (NASDAQ: MGRX), a company specializing in men's health and wellness products via telemedicine, has announced the formation of a Strategy and Alternatives Committee. The company's Board of Directors has initiated a process to evaluate potential strategic alternatives aimed at maximizing shareholder value.
These alternatives may include mergers, acquisitions, divestitures, business combinations...

Trytosaveabit

Oct 21 16:24

Summary of new 8K just filed

$Mangoceuticals (MGRX.US)$ On October 21, 2024, Mangoceuticals, Inc., also known as MangoRx, issued a press release to address and counter public claims made by pharmaceutical giant Eli Lilly. The claims pertain to allegations that MangoRx improperly replicated Eli Lilly's weight-loss medication, Zepbound and Mounjaro. MangoRx, listed on NASDAQ under the ticker MGRX, has categorically denied these allegations and has expressed its intention to vigorously defend itself ...